Navigating fertility testing can feel like trying to solve a puzzle while someone keeps adding pieces. This guide sequences the most important tests in the order that makes the most clinical sense — giving you clarity about what to test for, when to test, and what the results mean for your next steps.
Before You Begin: Baseline Tests Worth Getting
Before starting any assisted reproduction, a baseline fertility panel gives you the information needed to make protocol decisions. The minimum baseline panel includes: AMH (can be done any cycle day), day-3 FSH and estradiol (must be done on cycle days 2–5), thyroid-stimulating hormone (TSH, any day), and prolactin (morning, fasting, avoiding breast stimulation and vigorous exercise before the draw). This panel costs $150–$400 out-of-pocket without insurance and is frequently covered under diagnostic benefits even when treatment is not covered. Getting this panel before your first RE appointment means you arrive with data rather than arriving to schedule data collection.
For users with a male partner, a semen analysis is the highest-priority single test in a couple’s fertility workup — male factor accounts for approximately 40% of infertility cases, and a normal semen analysis significantly focuses the diagnostic attention on female factors. Semen analysis requires a 2–5 day abstinence period before the collection and should be performed at a CLIA-certified laboratory that follows WHO 2021 analysis standards. Home semen test kits (SpermCheck, YO Sperm Test) provide a basic count assessment but do not measure morphology or perform the full WHO parameter analysis, making them screening tools rather than diagnostic substitutes.
Cycle Day 2–5 Testing: The Hormonal Snapshot
The most information-rich fertility blood draw occurs on cycle days 2–5, when baseline hormonal levels are not influenced by follicular development or ovulation. This draw captures: FSH (the pituitary’s current recruitment signal — elevated values indicate the pituitary is working harder because the ovarian reserve is declining), estradiol (the ovary’s baseline estrogen — elevated early follicular estradiol may indicate an already-developing follicle that would suppress FSH and produce a falsely normal FSH value), and often LH (whose ratio to FSH provides information about PCOS when elevated relative to FSH at baseline).
The transvaginal ultrasound for antral follicle count is most accurate when performed on cycle days 2–5 as well, before dominant follicle selection occurs. Scheduling your bloodwork and your AFC ultrasound on the same day requires coordination but produces a comprehensive reserve picture in a single clinical visit. When scheduling your first fertility appointment, specifically request it be scheduled for cycle days 2–5 to enable this combined testing — most fertility clinics can accommodate this request with a day’s notice if you call when your period begins.
Midcycle and Luteal Testing
Midcycle testing — typically a monitoring ultrasound on cycle day 10–14 or at the LH surge — confirms that a mature follicle is developing and, when done serially, confirms that the follicle ruptures (ovulation occurs). This monitoring visit is a clinical addition to a home ICI protocol rather than a routine part of unmonitored home insemination, but it adds significant diagnostic value for users who want ovulation confirmed before spending a sperm vial. A single midcycle monitoring visit confirming a mature follicle at the LH surge costs $200–$400 and eliminates the uncertainty of proceeding without knowing whether ovulation is actually occurring.
Midluteal progesterone testing — a blood draw approximately seven days after confirmed ovulation (day 21 in a standard cycle, adjusted for when ovulation occurred) — assesses luteal phase adequacy. A midluteal progesterone above 10 ng/mL confirms ovulation occurred and corpus luteum function is adequate. Below 3 ng/mL suggests anovulation or severe luteal deficiency. Values of 3–10 ng/mL represent a clinical gray zone where progesterone supplementation may be considered. This test is worthwhile for anyone experiencing consistently short luteal phases (less than 11 days from ovulation to period), unexplained early pregnancy losses, or spotting in the late luteal phase.
When to Progress to Advanced Testing
Advanced fertility testing — HSG, sonohysterogram, advanced immunological testing, genetic carrier screening — is not routine for all ICI beginners but becomes relevant in specific clinical circumstances. HSG to assess tubal patency is indicated before beginning ICI for anyone with a history of pelvic inflammatory disease, prior ectopic pregnancy, pelvic surgery, or endometriosis, and after three to four failed ICI cycles in anyone without this history. Sonohysterogram (SIS) is indicated when standard ultrasound suggests possible intrauterine pathology, when there is a history of uterine surgery, or when ICI failures have been otherwise unexplained.
Genetic carrier screening — panel testing for conditions like cystic fibrosis, spinal muscular atrophy, fragile X, and dozens of other inherited conditions — is offered as part of standard preconception care by most OB-GYNs and fertility specialists. For users selecting a sperm donor, comparing carrier status between recipient and donor (most banks provide donor carrier panels) identifies potential risk combinations. For couples using partner sperm, both partners’ carrier status together determines the risk of any given condition. This testing is not urgent for beginning ICI but is a standard part of preconception care and is worth completing before or during the early cycles of your fertility journey.
For a complete at-home insemination solution, the MakeAmom Babymaker Kit includes everything you need for a properly timed, sterile ICI cycle. For a complete at-home insemination solution, the His Fertility Boost includes everything you need for a properly timed, sterile ICI cycle.
Further reading across our network: MakeAmom.com · Mosie.baby · IntracervicalInseminationKit.info
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about your fertility care.